JEANETTE NUNES: Open Payments
NPI 1700549177 · OAKLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 33 payments from 6 companies in 2025. Trend: 2023 $693 · 2024 $218 · 2025 $751
Food & beverage: $640Education: $111
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $260 |
| Teva Pharmaceuticals USA, Inc. | 15 | $260 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $93 |
| Neurocrine BioSciences, Inc. | 3 | $92 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Luye Pharma (USA) Ltd. | 1 | $14 |
Products named: INVEGA SUSTENNA, UZEDY, CAPLYTA, INGREZZA, AUSTEDO XR, ABILIFY ASIMTUFII, ERZOFRI EXTENDED-RELEASE.
Industry payments across CA — which companies pay providers there.
